NIH-funded research Career grant

Understanding Spp1+ Macrophages and Muscle Healing in Peripheral Artery Disease

Official title: Determining the Role of Spp1+ Macrophages in Muscle Regeneration in Peripheral Arterial Disease

Funded at Duke University · NIH-11401127 · Data updated 2026-11-12

This grant supports a physician-scientist in Duke's vascular surgery program to study how a specific macrophage type called Spp1+ macrophages affect muscle healing in people with peripheral artery disease.

More Peripheral Arterial Disease research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2027
Funding year2026
Award (this year)$153,144
NIH project number5K08HL171949-03
Project IDNIH-11401127 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include adults with peripheral arterial disease who have muscle injury or impaired muscle regeneration and are willing to participate in cellular or molecular studies.

Less likely to help

Patients without PAD or those not involved in muscle injury or regeneration studies may not benefit.

What this research studies

A surgeon-scientist will pursue three years of training and research to uncover how Spp1+ macrophages influence muscle repair in PAD. The project combines lab studies on immune and muscle cells with clinical insights from PAD patients to understand why some muscles don’t heal well after injury. The goal is to identify mechanisms that prevent proper muscle regeneration and to explore new cellular therapy approaches to preserve limb function. This program blends advanced coursework with hands-on experiments to build independence as a surgeon-scientist. The outcomes could guide future treatments to improve muscle recovery and reduce limb loss in PAD.

Why it matters

Potential benefit: If successful, the work could lead to new cellular therapies that improve muscle regeneration and reduce the risk of limb loss in PAD patients.

How similar studies have gone: Preliminary work has linked Spp1+ macrophages to poor muscle regeneration in PAD, suggesting potential for impactful findings but still requires validation.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Southerland, Kevin William — Duke University
  • Study coordinator: Southerland, Kevin William

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.